Judit Skopál Selected Research

4- aminobenzoyl- glycyl- prolyl- leucyl- alanine hydroxamic acid

4/2016

Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judit Skopál Research Topics

Disease

5	Stroke (Strokes) 04/2016 - 03/2002
5	Ischemic Stroke 02/2005 - 03/2002
4	Ischemia 04/2016 - 04/2009
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2008 - 03/2002
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2016 - 01/2015
2	Infarction (Infarctions) 04/2016 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 05/2010 - 09/2003
1	Cerebral Infarction 04/2016
1	Hereditary Angioedemas 10/2015
1	Vascular Remodeling 04/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Edema (Dropsy) 01/2015
1	Thrombophilia 02/2007
1	Atherosclerosis 02/2007
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 02/2005
1	Brain Edema (Cerebral Edema) 02/2005
1	Experimental Melanoma 01/2004
1	Inflammation (Inflammations) 09/2003
1	Thrombosis (Thrombus) 09/2003
1	Hypoxia (Hypoxemia) 09/2003
1	Hemorrhage 03/2002

Drug/Important Bio-Agent (IBA)

3	Immunoglobulin G (IgG)IBA 01/2008 - 03/2002
2	Matrix Metalloproteinases (MMPs)IBA 04/2016 - 09/2003
2	Pharmaceutical PreparationsIBA 04/2009 - 06/2002
2	FibrinIBA 01/2008 - 03/2002
2	Fibrinolysin FDA Link 01/2008 - 03/2002
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2008 - 11/2002
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2008 - 03/2002
1	Matrix Metalloproteinase InhibitorsIBA 04/2016
1	Nogo Receptor 1IBA 04/2016
1	GelatinasesIBA 04/2016
1	ChloridesIBA 04/2016
1	4- aminobenzoyl- glycyl- prolyl- leucyl- alanine hydroxamic acidIBA 04/2016
1	EnzymesIBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	Selegiline (E250)FDA LinkGeneric 01/2015
1	LigandsIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Jagged-1 ProteinIBA 01/2015
1	A-factor (Streptomyces)IBA 05/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2010
1	Estrogens (Estrogen)FDA Link 05/2010
1	Neuroprotective AgentsIBA 05/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2008
1	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)IBA 01/2008
1	PlasminogenIBA 01/2008
1	dipalmitoylphosphatidylserineIBA 01/2008
1	Apolipoproteins E (ApoE)IBA 02/2007
1	ApolipoproteinsIBA 02/2007
1	factor V LeidenIBA 02/2007
1	Thrombin FDA Link 07/2005
1	AntithrombinsIBA 07/2005
1	HirudinsIBA 07/2005
1	Fibrinogen (Factor I)FDA Link 07/2005
1	Factor XIII (Coagulation Factor XIII)IBA 07/2005
1	AnticoagulantsIBA 02/2005
1	ProstaglandinsIBA 02/2005
1	Complement System Proteins (Complement)IBA 02/2005
1	Endothelin-1 (Endothelin 1)IBA 02/2005
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2005
1	Heparin (Liquaemin)FDA LinkGeneric 01/2004
1	Peptide Hydrolases (Proteases)FDA Link 09/2003
1	CollagenIBA 09/2003
1	NF-kappa B (NF-kB)IBA 09/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2003
1	Streptokinase FDA Link 06/2002
1	beta-ThromboglobulinIBA 03/2002
1	von Willebrand FactorIBA 03/2002
1	ThrombomodulinIBA 03/2002

Therapy/Procedure

2	Therapeutics 05/2010 - 11/2002
1	Thrombolytic Therapy 06/2002